To obtain optimal conditions, the effect of contact time, initial Pb2+ concentration, and adsorbent dose were determined at laboratory temperature (27 °C) based on the following experiments: The effect of initial Pb2+ concentration was studied using 0.2 g of adsorbents and 50 ml of different concentrations of Pb2+ solution in the range of 10, 25, 50, 75 and 100 ppm in the screw-capped containers.
Dose was determined during randomization at baseline and coded as 0, 1, 2, or 3 representing the multiple of 6 SMT sessions each study group received.
In afatinib monotherapy trials, the maximum tolerated dose was determined to be continuous daily afatinib at either 40 mg or 50 mg [ 50, 51].
Surviving fraction at each dose was determined by the formula (number of surviving colonies in dose X)/(number of cells seeded for dose X × (average colonies arising from the non-irradiated cells (0 Gy)/number of non-irradiated cells seeded)) (Kimple et al, 2010).
The mean number of cocaine infusions at each unit dose was determined during two separate consecutive sessions.
To begin with, he said, the 300-milligram dose was determined by a world-renowned expert, Rudolph Bauer, a professor of pharmaceutical biology at the Karl-Franzens University in Graz, Austria.
In this phase I/II dose escalation study, the gemcitabine maximum tolerated dose (MTD) was determined at 1250 mg/m2, and a total of 92 patients were treated at this dose to establish safety and efficacy.
